Report - 0922 Gemtuzumab Ozogamicin (Mylotarg) - Aetna · 2020. 9. 4. · 95 % CI. Meta-analysis of 11 RCTs with 13 randomizations involving GO was undertaken. Although GO increased induction

Please pass captcha verification before submit form